New cancer clinical trial: Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients
Published on: November 16, 2017 at 10:00AM
Condition: Prostate Cancer
Interventions: Diagnostic Test: 68Ga-PSMA-11; Diagnostic Test: 18F-Choline PET-CT
Sponsor: Central Hospital, Nancy, France
Not yet recruiting
http://ift.tt/2zLzrse
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM